Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FRRK3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/ml. This firm fixed-price delivery order, awarded on January 5, 2026, represents the final completion date of January 6, 2026, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The order will be fulfilled at the vendor's Park Ridge location and supports the Department of Defense's pharmaceutical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract designated SPE2DR, which was awarded on November 13, 2025, under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC carries a $499.99 billion ceiling value through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract enables DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FRRK3?
SPE2DR26FRRK3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FRRK3 worth?
The government has obligated $2,494 on SPE2DR26FRRK3.
Is contract SPE2DR26FRRK3 an order under another contract?
Yes. SPE2DR26FRRK3 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRK3 competed?
The extent of competition for SPE2DR26FRRK3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award